Israel to expand COVID jab rollout to 12-15 age group
06/02/2021

Israel to expand COVID jab rollout to 12-15 age group

Israel’s health ministry announced Wednesday that children aged 12-15 would be able to receive...
read more
Final Results of National Institute of Allergy and Infectious Diseases’ ACTT-1 Trial Published in New England Journal of Medicine Expand Clinical Benefits of Veklury® (remdesivir) for the Treatment of COVID-19
10/12/2020

Final Results of National Institute of Allergy and Infectious Diseases’ ACTT-1 Trial Published in New England Journal of Medicine Expand Clinical Benefits of Veklury® (remdesivir) for the Treatment of COVID-19

FOSTER CITY, Calif.–(BUSINESS WIRE)–Oc...
read more